New Products

A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.

Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.

The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.

Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.

A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.

Seventy-one percent of women miss their first perimenopausal symptom because anxiety, brain fog, and mood changes precede hot flashes—and most attribute them to stress, per the Bonafide 2026 State of Menopause Survey.

A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.